BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31103822)

  • 1. WD repeat and SOCS box containing protein 2 in the proliferation, cycle progression, and migration of melanoma cells.
    Zhang Y; Li Z; Zhao W; Hu H; Zhao L; Zhu Y; Yang X; Gao B; Yang H; Huang Y; Song X
    Biomed Pharmacother; 2019 Aug; 116():108974. PubMed ID: 31103822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WSB2 as a target of Hedgehog signaling promoted the malignant biological behavior of Xuanwei lung cancer through regulating Wnt/β-catenin signaling.
    Wei X; Liao J; Lei Y; Li M; Zhao G; Zhou Y; Ye L; Huang Y
    Transl Cancer Res; 2020 Dec; 9(12):7394-7404. PubMed ID: 35117340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovostatin 2 knockdown significantly inhibits the growth, migration, and tumorigenicity of cutaneous malignant melanoma cells.
    Huang YX; Song H; Tao Y; Shao XB; Zeng XS; Xu XL; Qi JL; Sun JF
    PLoS One; 2018; 13(4):e0195610. PubMed ID: 29684087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G
    Yang XH; Xia T; Zhang J; Yang SF; Tang HX; Tang T; Huang ZC; Zhong YS; He F; Xiang AP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):895-903. PubMed ID: 29270750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR‑28‑5p inhibits the migration of breast cancer by regulating WSB2.
    Ma L; Zhang Y; Hu F
    Int J Mol Med; 2020 Oct; 46(4):1562-1570. PubMed ID: 32945370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZNF750 inhibits the proliferation and invasion of melanoma cells through modulating the Wnt/b-catenin signaling pathway.
    Du Y; Lv G; Jing C; Liu J; Liu J
    Folia Histochem Cytobiol; 2020; 58(4):255-263. PubMed ID: 33185885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CDKN2A (p16INK4A/p14ARF) Over-Expression on Proliferation and Migration of Human Melanoma A375 Cells.
    Bai M; Yu NZ; Long F; Feng C; Wang XJ
    Cell Physiol Biochem; 2016; 40(6):1367-1376. PubMed ID: 27997910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZC3H15 Correlates with a Poor Prognosis and Tumor Progression in Melanoma.
    Li Q; Hou J; Guo C; Zhang Y; Liu L; Hu H; Shi S; Ji Y; Guo L; Shi Y; Liu Y; Cui H
    Biomed Res Int; 2021; 2021():8305299. PubMed ID: 34988227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of Delta-like 3 restricts lipopolysaccharide-induced inflammation, migration and invasion of A2058 melanoma cells via blocking Twist1-mediated epithelial-mesenchymal transition.
    Ding X; Li F; Zhang L
    Life Sci; 2019 Jun; 226():149-155. PubMed ID: 30981764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted knockdown of polo-like kinase 1 alters metabolic regulation in melanoma.
    Gutteridge RE; Singh CK; Ndiaye MA; Ahmad N
    Cancer Lett; 2017 May; 394():13-21. PubMed ID: 28235541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway.
    Thu YM; Su Y; Yang J; Splittgerber R; Na S; Boyd A; Mosse C; Simons C; Richmond A
    Oncogene; 2012 May; 31(20):2580-92. PubMed ID: 21963849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-32α induces migration of human melanoma cells through downregulation of E-cadherin.
    Lee J; Kim KE; Cheon S; Song JH; Houh Y; Kim TS; Gil M; Lee KJ; Kim S; Kim D; Hur DY; Yang Y; Bang SI; Park HJ; Cho D
    Oncotarget; 2016 Oct; 7(40):65825-65836. PubMed ID: 27589563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of dickkopf-1 enhances the proliferation and osteogenic potential of fibroblasts isolated from ankylosing spondylitis patients via the Wnt/β-catenin signaling pathway in vitro.
    Zou YC; Yang XW; Yuan SG; Zhang P; Ye YL; Li YK
    Connect Tissue Res; 2016 May; 57(3):200-11. PubMed ID: 26837533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNAi-mediated downregulation of CDKL1 inhibits growth and colony-formation ability, promotes apoptosis of human melanoma cells.
    Song Z; Lin J; Sun Z; Ni J; Sha Y
    J Dermatol Sci; 2015 Jul; 79(1):57-63. PubMed ID: 25920913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RASSF1A suppresses melanoma development by modulating apoptosis and cell-cycle progression.
    Yi M; Yang J; Chen X; Li J; Li X; Wang L; Tan Y; Xiong W; Zhou M; McCarthy JB; Li G; Xiang B; Xie H
    J Cell Physiol; 2011 Sep; 226(9):2360-9. PubMed ID: 21660959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
    Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
    BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN.
    Mao XH; Chen M; Wang Y; Cui PG; Liu SB; Xu ZY
    Mol Carcinog; 2017 Mar; 56(3):886-894. PubMed ID: 27533779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant G6PD levels promote tumor cell proliferation or apoptosis via the STAT3/5 pathway in the human melanoma xenograft mouse model.
    Hu T; Zhang C; Tang Q; Su Y; Li B; Chen L; Zhang Z; Cai T; Zhu Y
    BMC Cancer; 2013 May; 13():251. PubMed ID: 23693134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand Bound Fatty Acid Binding Protein 7 (FABP7) Drives Melanoma Cell Proliferation Via Modulation of Wnt/β-Catenin Signaling.
    Umaru BA; Kagawa Y; Shil SK; Arakawa N; Pan Y; Miyazaki H; Kobayashi S; Yang S; Cheng A; Wang Y; Shinoda Y; Kiniwa Y; Okuyama R; Fukunaga K; Owada Y
    Pharm Res; 2021 Mar; 38(3):479-490. PubMed ID: 33646504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Citron kinase (CIT-K) promotes aggressiveness and tumorigenesis of breast cancer cells in vitro and in vivo: preliminary study of the underlying mechanism.
    Meng D; Yu Q; Feng L; Luo M; Shao S; Huang S; Wang G; Jing X; Tong Z; Zhao X; Liu R
    Clin Transl Oncol; 2019 Jul; 21(7):910-923. PubMed ID: 30565087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.